Analysis of the human vasoactive intestinal peptide (VIP)1 receptor gene promoter

被引：0
|
作者：
Sreedharan, SP
Mu, Y
Kong, Y
Goetzl, EJ
机构：
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Immunol & Microbiol, San Francisco, CA 94143 USA
来源：
FASEB JOURNAL | 1997年 / 11卷 / 09期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
399
引用
收藏
页码：A925 / A925
页数：1
相关论文
共 50 条
  • [21] REGULATION OF THE HUMAN AND MOUSE VASOACTIVE-INTESTINAL-PEPTIDE (VIP) GENES
    WASCHEK, JA
    KRAJNIAK, KG
    BRAVO, DT
    AGOSTON, DV
    BIOMEDICAL RESEARCH-TOKYO, 1992, 13 : 1 - 6
  • [22] BEHAVIORAL ACTIONS OF VASOACTIVE INTESTINAL PEPTIDE (VIP)
    COTTRELL, GA
    VELDHUIS, HD
    ROSTENE, WH
    DEKLOET, ER
    NEUROPEPTIDES, 1984, 4 (04) : 331 - 341
  • [23] SYNTHESIS OF AVIAN VASOACTIVE INTESTINAL PEPTIDE (VIP)
    BODANSZKY, M
    BODANSZKY, A
    SAID, SI
    FEDERATION PROCEEDINGS, 1978, 37 (06) : 1829 - 1829
  • [24] REGULATION OF HUMAN VASOACTIVE-INTESTINAL-PEPTIDE (VIP) GENE BY CYCLIC-AMP AND PHORBOL ESTERS
    FINK, JS
    TSUDAKA, T
    MANDEL, G
    GOODMAN, R
    NEUROLOGY, 1986, 36 (04) : 256 - 256
  • [25] PHARMACOLOGICAL ANALYSIS OF THE MESENTERIC VASODILATOR EFFECT OF VASOACTIVE INTESTINAL PEPTIDE (VIP)
    KACHELHOFFER, J
    MARESCAUX, J
    SAVA, P
    GRENIER, JF
    BRITISH JOURNAL OF SURGERY, 1979, 66 (12) : 892 - 892
  • [26] VASOACTIVE-INTESTINAL-PEPTIDE (VIP) RECEPTOR IMAGING IN THE LOCALIZATION OF INTESTINAL ADENOCARCINOMAS AND ENDOCRINE TUMORS
    VIRGOLINI, I
    RADERER, M
    ANGELBERGER, P
    BANYAI, S
    SCHEITHAUER, W
    VALENT, P
    JOURNAL OF NUCLEAR MEDICINE, 1994, 35 (05) : P97 - P97
  • [27] Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells
    Jiang, SP
    Kopras, E
    McMichael, M
    Bell, RH
    Ulrich, CD
    CANCER RESEARCH, 1997, 57 (08) : 1475 - 1480
  • [28] Breast cancer growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonist
    Zia, H
    Hida, T
    Jakowlew, S
    Birrer, M
    Gozes, Y
    Reubi, JC
    Fridkin, M
    Gozes, I
    Moody, TW
    CANCER RESEARCH, 1996, 56 (15) : 3486 - 3489
  • [29] Vasoactive intestinal peptide (VIP) receptor type 2 (VPAC2) is the predominant receptor expressed in human thymocytes
    Lara-Marquez, ML
    O'Dorisio, MS
    Karacay, B
    VIP, PACAP, GLUCAGON, AND RELATED PEPTIDES, 2000, 921 : 45 - 54
  • [30] MUTATIONAL ANALYSIS OF CYSTEINE RESIDUES WITHIN THE EXTRACELLULAR DOMAINS OF THE HUMAN VASOACTIVE-INTESTINAL-PEPTIDE (VIP) 1-RECEPTOR IDENTIFIES 7 MUTANTS THAT ARE DEFECTIVE IN VIP BINDING
    GAUDIN, P
    COUVINEAU, A
    MAORET, JJ
    ROUYERFESSARD, C
    LABURTHE, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 211 (03) : 901 - 908
12345